Featured Research

from universities, journals, and other organizations

If Caught Early, High Rates Of Arthritis Remission Can Be Achieved

Date:
November 12, 2007
Source:
American College of Rheumatology
Summary:
In early inflammatory arthritis, higher rates of remission are achieved if treatment is started early with conventional therapies and patients are more closely followed, according to new research.

In early inflammatory arthritis, higher rates of remission are achieved if treatment is started early with conventional therapies and patients are more closely followed, according to research presented recently at the American College of Rheumatology Annual Scientific Meeting in Boston.

Using the Toronto Early Arthritis CoHort, a prospective observational cohort of 103 patients with early inflammatory arthritis, investigators set out to determine how many patients reached remission 12 months after the initiation of DMARD (disease-modifying antirheumatic drug) therapy. Investigators also compared the different methods of measuring remission currently in use by clinicians.

The average age of the patients was 46 years, and 80% were female. All had symptoms of early arthritis for more than six weeks but for less than 12 months, and all had two or more swollen joints or one swollen joint in the hand plus one additional symptom of arthritis (e.g., morning stiffness). Fifty-nine percent of patients in the cohort initiated combination DMARD therapy (methotrexate plus another DMARD such as sulfasalazine or hydroxychloroquine); 40 percent started only methotrexate. The methotrexate dose was somewhat higher than usually reached, with 35 percent of patients taking 20 to 25 mg per week. At six and 12 months, 13 percent and 28 percent of the patients had initiated biologic therapy, respectively. By 12 months, only 20% of patients required biologic therapies.

While some remission criteria are more stringent than others, at the end of the 12 month period approximately half of the patients were able to achieve remission as a result of having prompted started an optimal DMARD therapy.

“This study highlights the benefits of early DMARD therapy, ideally in combination, using a higher dose of methotrexate,” said Vivian Bykerk, MD, University of Toronto, and lead investigator in the study. “However further investigations are needed to identify those who will and will not benefit from this initial strategy and those who require a more aggressive treatment strategy.”


Story Source:

The above story is based on materials provided by American College of Rheumatology. Note: Materials may be edited for content and length.


Cite This Page:

American College of Rheumatology. "If Caught Early, High Rates Of Arthritis Remission Can Be Achieved." ScienceDaily. ScienceDaily, 12 November 2007. <www.sciencedaily.com/releases/2007/11/071109204221.htm>.
American College of Rheumatology. (2007, November 12). If Caught Early, High Rates Of Arthritis Remission Can Be Achieved. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2007/11/071109204221.htm
American College of Rheumatology. "If Caught Early, High Rates Of Arthritis Remission Can Be Achieved." ScienceDaily. www.sciencedaily.com/releases/2007/11/071109204221.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Respiratory Virus Spreads To Northeast, Now In 21 States

Respiratory Virus Spreads To Northeast, Now In 21 States

Newsy (Sep. 14, 2014) The respiratory virus Enterovirus D68, which targets children, has spread from the Midwest to 21 states. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins